CRISPR
UK asks to use CRISPR on human embryos
UK scientists have applied to the country’s fertility regulator for permission to use CRISPR and other genome editing techniques on human embryos.
CRISPR
UK scientists have applied to the country’s fertility regulator for permission to use CRISPR and other genome editing techniques on human embryos.
Sandoz has reiterated its call for US FDA guidance on biosimilar interchangeability arguing that the lack of clarity makes it hard to gauge what impact switching rules will have on pricing.